Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-102532
Filing Date
2016-05-16
Accepted
2016-05-16 16:01:20
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v438737_10q.htm 10-Q 424584
2 EXHIBIT 31.1 v438737_ex31-1.htm EX-31.1 8055
3 EXHIBIT 32.1 v438737_ex32-1.htm EX-32.1 4147
  Complete submission text file 0001144204-16-102532.txt   4277184

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT arni-20160331.xml EX-101.INS 1110277
5 XBRL TAXONOMY EXTENSION SCHEMA arni-20160331.xsd EX-101.SCH 50760
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20160331_cal.xml EX-101.CAL 20395
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20160331_def.xml EX-101.DEF 247050
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20160331_lab.xml EX-101.LAB 331532
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20160331_pre.xml EX-101.PRE 278359
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52153 | Film No.: 161653528
SIC: 2834 Pharmaceutical Preparations